When the Justice Department Goes Soft on Corporate Health Crimes

For eight years, Alibaba and its U.S. payment processor let dangerous drugs, chemicals, and pill presses flow to American customers. Employees reported compliance failures. Investigators from multiple agencies dug in. Prosecutors believed they had felony violations dead to rights.

Then the case settled for $600 million with a non-prosecution agreement, meaning Alibaba admitted only to misdemeanors, not felonies. No prosecution. No accountability in any meaningful sense.

"There was egregious conduct by a Chinese-owned company," one person familiar with the evidence told CBS News. "An NPA is not even a slap on the wrist."

Why This Matters

This isn't an outlier. The CBS investigation found this is part of a pattern: Justice Department leadership dropping support or closing criminal investigations into companies selling defective CPAP machines, contaminated baby formula, and other products that put lives at risk. In case after case, investigators found evidence consumers faced "significant risk of harm from defective or adulterated products."

There's a principle at stake here. Regular people go to prison for drug crimes. Companies that knowingly distribute them to Americans get a settlement and a press release calling it a victory.

The Food, Drug and Cosmetic Act, the law on the books since 1938, says it's illegal to sell counterfeit, adulterated, or misbranded drugs. That law exists because people died. It exists because we decided, as a country, that this matters enough to have rules with teeth.

What Selective Enforcement Costs

When corporate crime enforcement becomes a political choice instead of a legal one, two things happen. First, companies learn the calculation: if you might get caught, the fine is just a business expense. Second, people lose trust that the rules apply equally.

A justice system that prosecutes individuals for drug possession but negotiates with corporations that knowingly distribute dangerous drugs isn't justice. It's privilege.

The DOJ responded to CBS that it "does not believe in regulation by prosecution." That's a choice. But it's worth asking: what does corporate accountability look like if prosecution is off the table? A fine that a multinational corporation writes down as a tax deduction? A non-prosecution agreement that amounts to admitting nothing?

The Bigger Picture

This is what happens when corporate power isn't checked by actual rules with actual consequences. When enforcement is selective. When politics matters more than law.

The Common Good Party's position on corporate power is simple: competition requires rules. When corporations write them, or when enforcement gets soft because of who's in office, the system isn't working for you.